Pilot study: a detailed analysis of the timing of immuno-inflammatory indices in gastric cancer, and their assessment together with TNM as supplementary prognostic factors.

Autor:	Sánchez Fuentes PA; Cirugía General y del Aparato Digestivo, Hospital Universitario Torrecárdenas, España., Ruiz-Pardo J; Cirugia General y del Aparato Digestivo, Hospital Universitario Torrecárdenas., Vidaña Márquez E; Cirugía General y del Aparato Digestivo, Hospital Universitario Torrecárdenas., Belda Lozano R; Cirugía General y del Aparato Digestivo, Hospital Universitario Torrecárdenas, España., Ferrer-Márquez M; Cirugía General y del Aparato Digestivo, Hospital Universitario Torrecárdenas, España., Reina Duarte Á; Cirugía General y del Aparato Digestivo, Hospital Universitario Torrecárdenas, España.
Jazyk:	angličtina
Zdroj:	Revista espanola de enfermedades digestivas [Rev Esp Enferm Dig] 2024 Jan; Vol. 116 (1), pp. 46-47.
DOI:	10.17235/reed.2023.9548/2023
Abstrakt:	An analysis of the prognostic impact of up to 36 immuno-inflammatory indices at 3 different times during the diagnostic-therapeutic process for gastric cancer. The dependent variable was disease-free survival at 3 years. The independent factors obtained were combined with TNM to provide an improved prognostic model.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu